Immunohistochemical analysis of p53 mutations in bronchioalveolar carcinoma and conventional pulmonary adenocarcinoma

Xiaobin Wang, M. Sambasiva Rao, A. V. Yeldandi

Research output: Contribution to journalArticle

Abstract

Mutations of p53 tumor suppressor gene have been shown to contribute to tumorigenesis in a variety of human cancers. Normally, p53 protein degrades rapidly and is not detected by immunohistochemical procedure, but mutant p53 and wild-type p53 stabilized by certain viral oncoproteins can accumulate to immunohistochemically demonstrable levels. Conventional pulmonary adenocarcinomas and bronchioalveolar carcinomas, although morphologically similar, exhibit different biological behavior and clinical prognosis. To explore the differences in the expression of p53 protein in these two tumor types, we performed immunohistochemistry on 10 conventional pulmonary adenocarcinomas and 12 bronchioalveolar carcinomas on formalin-fixed and paraffin-embedded material, using the commercially available monoclonal antibody against the mutant p53 protein. Intense nuclear staining was observed in 80% (8/10) of conventional pulmonary adenocarcinomas, whereas all 12 bronchioalveolar carcinomas were negative for p53 protein. These observations indicate that altered p53 protein (probably mutant) is overexpressed in conventional adenocarcinomas and may be involved in its tumorigenesis or progression. On the other hand, the lack of p53 expression in bronchioalveolar carcinomas suggests that an alternative pathway is likely to be responsible for its tumorigenesis. Furthermore, p53 protein immunostaining may be useful as an adjunct in differentiating conventional pulmonary adenocarcinomas from bronchioalveolar carcinomas.

Original languageEnglish (US)
Pages (from-to)919-923
Number of pages5
JournalModern Pathology
Volume8
Issue number9
StatePublished - 1995
Externally publishedYes

Fingerprint

Carcinoma
Mutation
Carcinogenesis
Mutant Proteins
Proteins
Oncogene Proteins
Tumor Suppressor Genes
Paraffin
Formaldehyde
Neoplasms
Adenocarcinoma
Immunohistochemistry
Monoclonal Antibodies
Adenocarcinoma of lung
Staining and Labeling

Keywords

  • bronchioalveolar carcinoma
  • conventional pulmonary adenocarcinoma
  • immunohistochemistry
  • p53 tumor suppressor gene

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Immunohistochemical analysis of p53 mutations in bronchioalveolar carcinoma and conventional pulmonary adenocarcinoma. / Wang, Xiaobin; Sambasiva Rao, M.; Yeldandi, A. V.

In: Modern Pathology, Vol. 8, No. 9, 1995, p. 919-923.

Research output: Contribution to journalArticle

@article{2695e0895e9a455ba24885ab8492ea8c,
title = "Immunohistochemical analysis of p53 mutations in bronchioalveolar carcinoma and conventional pulmonary adenocarcinoma",
abstract = "Mutations of p53 tumor suppressor gene have been shown to contribute to tumorigenesis in a variety of human cancers. Normally, p53 protein degrades rapidly and is not detected by immunohistochemical procedure, but mutant p53 and wild-type p53 stabilized by certain viral oncoproteins can accumulate to immunohistochemically demonstrable levels. Conventional pulmonary adenocarcinomas and bronchioalveolar carcinomas, although morphologically similar, exhibit different biological behavior and clinical prognosis. To explore the differences in the expression of p53 protein in these two tumor types, we performed immunohistochemistry on 10 conventional pulmonary adenocarcinomas and 12 bronchioalveolar carcinomas on formalin-fixed and paraffin-embedded material, using the commercially available monoclonal antibody against the mutant p53 protein. Intense nuclear staining was observed in 80{\%} (8/10) of conventional pulmonary adenocarcinomas, whereas all 12 bronchioalveolar carcinomas were negative for p53 protein. These observations indicate that altered p53 protein (probably mutant) is overexpressed in conventional adenocarcinomas and may be involved in its tumorigenesis or progression. On the other hand, the lack of p53 expression in bronchioalveolar carcinomas suggests that an alternative pathway is likely to be responsible for its tumorigenesis. Furthermore, p53 protein immunostaining may be useful as an adjunct in differentiating conventional pulmonary adenocarcinomas from bronchioalveolar carcinomas.",
keywords = "bronchioalveolar carcinoma, conventional pulmonary adenocarcinoma, immunohistochemistry, p53 tumor suppressor gene",
author = "Xiaobin Wang and {Sambasiva Rao}, M. and Yeldandi, {A. V.}",
year = "1995",
language = "English (US)",
volume = "8",
pages = "919--923",
journal = "Modern Pathology",
issn = "0893-3952",
publisher = "Nature Publishing Group",
number = "9",

}

TY - JOUR

T1 - Immunohistochemical analysis of p53 mutations in bronchioalveolar carcinoma and conventional pulmonary adenocarcinoma

AU - Wang, Xiaobin

AU - Sambasiva Rao, M.

AU - Yeldandi, A. V.

PY - 1995

Y1 - 1995

N2 - Mutations of p53 tumor suppressor gene have been shown to contribute to tumorigenesis in a variety of human cancers. Normally, p53 protein degrades rapidly and is not detected by immunohistochemical procedure, but mutant p53 and wild-type p53 stabilized by certain viral oncoproteins can accumulate to immunohistochemically demonstrable levels. Conventional pulmonary adenocarcinomas and bronchioalveolar carcinomas, although morphologically similar, exhibit different biological behavior and clinical prognosis. To explore the differences in the expression of p53 protein in these two tumor types, we performed immunohistochemistry on 10 conventional pulmonary adenocarcinomas and 12 bronchioalveolar carcinomas on formalin-fixed and paraffin-embedded material, using the commercially available monoclonal antibody against the mutant p53 protein. Intense nuclear staining was observed in 80% (8/10) of conventional pulmonary adenocarcinomas, whereas all 12 bronchioalveolar carcinomas were negative for p53 protein. These observations indicate that altered p53 protein (probably mutant) is overexpressed in conventional adenocarcinomas and may be involved in its tumorigenesis or progression. On the other hand, the lack of p53 expression in bronchioalveolar carcinomas suggests that an alternative pathway is likely to be responsible for its tumorigenesis. Furthermore, p53 protein immunostaining may be useful as an adjunct in differentiating conventional pulmonary adenocarcinomas from bronchioalveolar carcinomas.

AB - Mutations of p53 tumor suppressor gene have been shown to contribute to tumorigenesis in a variety of human cancers. Normally, p53 protein degrades rapidly and is not detected by immunohistochemical procedure, but mutant p53 and wild-type p53 stabilized by certain viral oncoproteins can accumulate to immunohistochemically demonstrable levels. Conventional pulmonary adenocarcinomas and bronchioalveolar carcinomas, although morphologically similar, exhibit different biological behavior and clinical prognosis. To explore the differences in the expression of p53 protein in these two tumor types, we performed immunohistochemistry on 10 conventional pulmonary adenocarcinomas and 12 bronchioalveolar carcinomas on formalin-fixed and paraffin-embedded material, using the commercially available monoclonal antibody against the mutant p53 protein. Intense nuclear staining was observed in 80% (8/10) of conventional pulmonary adenocarcinomas, whereas all 12 bronchioalveolar carcinomas were negative for p53 protein. These observations indicate that altered p53 protein (probably mutant) is overexpressed in conventional adenocarcinomas and may be involved in its tumorigenesis or progression. On the other hand, the lack of p53 expression in bronchioalveolar carcinomas suggests that an alternative pathway is likely to be responsible for its tumorigenesis. Furthermore, p53 protein immunostaining may be useful as an adjunct in differentiating conventional pulmonary adenocarcinomas from bronchioalveolar carcinomas.

KW - bronchioalveolar carcinoma

KW - conventional pulmonary adenocarcinoma

KW - immunohistochemistry

KW - p53 tumor suppressor gene

UR - http://www.scopus.com/inward/record.url?scp=0029613853&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029613853&partnerID=8YFLogxK

M3 - Article

C2 - 8751332

AN - SCOPUS:0029613853

VL - 8

SP - 919

EP - 923

JO - Modern Pathology

JF - Modern Pathology

SN - 0893-3952

IS - 9

ER -